110 related articles for article (PubMed ID: 38517251)
61. Computational evaluation of quinones of
Roney M; Dubey A; Nasir MH; Huq AM; Tufail A; Tajuddin SN; Zamri NB; Mohd Aluwi MFF
J Biomol Struct Dyn; 2023 Aug; ():1-11. PubMed ID: 37632317
[No Abstract] [Full Text] [Related]
62. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
63. Identification of 3, 4-dihydroxy complexes as potential antiviral via DFT, molecular docking, molecular dynamics and MM/PBSA against rabies and dengue receptors.
Sinha P; Yadav AK
J Biomol Struct Dyn; 2023 Aug; ():1-17. PubMed ID: 37580968
[TBL] [Abstract][Full Text] [Related]
64. Modelling studies reveal the importance of the C-terminal inter motif loop of NSP1 as a promising target site for drug discovery and screening of potential phytochemicals to combat SARS-CoV-2.
Prabhu D; Rajamanikandan S; Sureshan M; Jeyakanthan J; Saraboji K
J Mol Graph Model; 2021 Jul; 106():107920. PubMed ID: 33933885
[TBL] [Abstract][Full Text] [Related]
65. Identification of potential bioactive natural compounds from Indonesian medicinal plants against 3-chymotrypsin-like protease (3CL
Prasetyo WE; Purnomo H; Sadrini M; Wibowo FR; Firdaus M; Kusumaningsih T
J Biomol Struct Dyn; 2023 Jul; 41(10):4467-4484. PubMed ID: 35470785
[TBL] [Abstract][Full Text] [Related]
66. Inhibitor screening for volume-sensitive LRRC8A chloride channel.
Liu C; Cui W; Zhu K; Yuan S; Sun L; Liang Y; Lu J; Li D; Deng Z; Duan L; Zhang W; Yu X; Wang D; Zhang H
J Biomol Struct Dyn; 2023 Oct; ():1-9. PubMed ID: 37902556
[TBL] [Abstract][Full Text] [Related]
67. Identification of sequence motifs involved in Dengue virus-host interactions.
Asnet Mary J; Paramasivan R; Shenbagarathai R
J Biomol Struct Dyn; 2016; 34(3):676-87. PubMed ID: 25905427
[TBL] [Abstract][Full Text] [Related]
68. Virtual screening and molecular dynamics investigations using natural compounds against autotaxin for the treatment of chronic pain.
Akhilesh ; Menon A; Agrawal S; Chouhan D; Gadepalli A; Das B; Kumar R; Singh N; Tiwari V
J Biomol Struct Dyn; 2024 Jan; ():1-21. PubMed ID: 38285669
[TBL] [Abstract][Full Text] [Related]
69. Designing of nanobodies against Dengue virus Capsid: a computational affinity maturation approach.
Chaudhuri D; Majumder S; Datta J; Giri K
J Biomol Struct Dyn; 2023 Apr; 41(6):2289-2299. PubMed ID: 35067204
[TBL] [Abstract][Full Text] [Related]
70. Isatin-based virtual high throughput screening, molecular docking, DFT, QM/MM, MD and MM-PBSA study of novel inhibitors of SARS-CoV-2 main protease.
Varadharajan V; Arumugam GS; Shanmugam S
J Biomol Struct Dyn; 2022 Oct; 40(17):7852-7867. PubMed ID: 33764269
[TBL] [Abstract][Full Text] [Related]
71. Interaction of Bioactive Compounds of Moringa oleifera Leaves with SARS-CoV-2 Proteins to Combat COVID-19 Pathogenesis: a Phytochemical and In Silico Analysis.
Siddiqui S; Upadhyay S; Ahmad R; Barkat MA; Jamal A; Alothaim AS; Hassan MZ; Rahman MA; Arshad M; Ahamad T; Khan MF; Shankar H; Ali M; Kaleem S; Ahmad J
Appl Biochem Biotechnol; 2022 Dec; 194(12):5918-5944. PubMed ID: 35838886
[TBL] [Abstract][Full Text] [Related]
72. A Transcriptomics-Based Bioinformatics Approach for Identification and In Vitro Screening of FDA-Approved Drugs for Repurposing against Dengue Virus-2.
Punekar M; Kasabe B; Patil P; Kakade MB; Parashar D; Alagarasu K; Cherian S
Viruses; 2022 Sep; 14(10):. PubMed ID: 36298705
[TBL] [Abstract][Full Text] [Related]
73.
Panchal R; Bapat S; Mukherjee S; Chowdhary A
Indian J Pharmacol; 2021; 53(6):471-479. PubMed ID: 34975135
[TBL] [Abstract][Full Text] [Related]
74. Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry.
Kuo YT; Liu CH; Li JW; Lin CJ; Jassey A; Wu HN; Perng GC; Yen MH; Lin LT
Sci Rep; 2020 Oct; 10(1):16378. PubMed ID: 33009425
[TBL] [Abstract][Full Text] [Related]
75. Identification of acridinedione scaffolds as potential inhibitor of DENV-2 C protein: An in silico strategy to combat dengue.
Kumar S; Bhardwaj VK; Singh R; Das P; Purohit R
J Cell Biochem; 2022 May; 123(5):935-946. PubMed ID: 35315127
[TBL] [Abstract][Full Text] [Related]
76. Looking for inhibitors of the dengue virus NS5 RNA-dependent RNA-polymerase using a molecular docking approach.
Galiano V; Garcia-Valtanen P; Micol V; Encinar JA
Drug Des Devel Ther; 2016; 10():3163-3181. PubMed ID: 27784988
[TBL] [Abstract][Full Text] [Related]
77. Screening of potential bio-molecules from
Mathpal S; Sharma P; Joshi T; Joshi T; Pande V; Chandra S
J Biomol Struct Dyn; 2022; 40(20):9885-9896. PubMed ID: 34151733
[TBL] [Abstract][Full Text] [Related]
78. Advances in Computational Methods to Discover New NS2B-NS3 Inhibitors Useful Against Dengue and Zika Viruses.
Dos Santos Nascimento IJ; da Silva Rodrigues ÉE; da Silva MF; de Araújo-Júnior JX; de Moura RO
Curr Top Med Chem; 2022; 22(29):2435-2462. PubMed ID: 36415099
[TBL] [Abstract][Full Text] [Related]
79. Pharmacophore modeling, molecular docking and molecular dynamics simulation for screening and identifying anti-dengue phytocompounds.
Vora J; Patel S; Athar M; Sinha S; Chhabria MT; Jha PC; Shrivastava N
J Biomol Struct Dyn; 2020 Apr; 38(6):1726-1740. PubMed ID: 31057055
[TBL] [Abstract][Full Text] [Related]
80. Structure-based drug designing against
Sarma M; Borkotoky S; Dubey VK
J Biomol Struct Dyn; 2023 Jul; ():1-9. PubMed ID: 37491862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
